Rajender Hanmiah

Rajender Hanmiah, an academic internist with 27 years of experience, shares insights from the Canadian Conference of Internal Medicine. He discusses innovative blood biomarkers for Alzheimer's diagnosis and critical findings on atrial fibrillation risks. The conversation dives into promising new treatments for NASH, alongside challenges in drug trials, including significant side effects. Key highlights also cover the intersection of liver disease, long COVID, and the importance of continued vaccination efforts in tackling public health issues.